COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.97 · baric_ti:utt:00846

Page text: p.97 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker
Christina Salazar
But that was part --

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Christina Salazar open
    But where was that portion? So I think --
  2. 2026-04-10 09:00 Ralph S. Baric open
    Well, that would've had to have been done in China because it was based on the strains that would be found in the cave complex that they were doing their discovery work.
  3. 2026-04-10 09:00 Christina Salazar open
    I recall that there was some Michigan --
  4. 2026-04-10 09:00 Ralph S. Baric open
    Yeah. There was a Michigan group that had these kind of sprayers -- DC.Scheduling@LexitasLegal.com
  5. 2026-04-10 09:00 Christina Salazar
    But that was part --
  6. 2026-04-10 09:00 Ralph S. Baric open
    Yeah, that was part of it, but the Michigan group also had a vaccine vector where we would put in viral antigens to try to immunize the bats.
  7. 2026-04-10 09:00 Christina Salazar open
    And I think that there was, in the actual proposal, there was discussion about going to caves in Michigan. So to me that sounds like we might have been doing this in the United States as opposed to China.
  8. 2026-04-10 09:00 Ralph S. Baric open
    If they were doing it in Michigan, what they were doing were pilot experiments to see if the approach, especially the double-stranded RNA approach, reduced virus titers for North American strains. And there's no sarbecoviruses in North America at this time.
  9. 2026-04-10 09:00 Christina Salazar open
    So what they would be spraying in the caves would not be the gain-of-function?

Full conversation →